Comparison of caffeine-induced changes in cerebral blood flow and middle cerebral artery blood velocity shows that caffeine reduces middle cerebral artery diameter

Physiological Measurement

Volumn 25, Issue 2, 2004, Pages 467-474

  Lunt, M J ^a   Ragab, S ^a   Birch, A A ^b   Schley, D ^b   Jenkinson, D F ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Arterial diameter; Blood flow velocity; Caffeine; Cerebral blood flow; Transcranial Doppler; Xenon clearance

Indexed keywords

BLOOD; CAFFEINE; FLOW VELOCITY; HEMODYNAMICS; PATIENT REHABILITATION; XENON;

ACUTE STROKE; ARTERIAL DIAMETER; ARTERY BLOOD VELOCITY; BLOOD FLOW VELOCITY; CEREBRAL BLOOD FLOW; CONFIDENCE INTERVAL; MEASUREMENTS OF; MIDDLE CEREBRAL ARTERY; TRANSCRANIAL DOPPLER; XENON CLEARANCE;

BLOOD VESSELS;

CAFFEINE; PLACEBO; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; XENON;

ADULT; AGED; ARTERIOLE; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; HUMAN; MEASUREMENT; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 2342619587     PISSN: 09673334     EISSN: None     Source Type: Journal    
DOI: 10.1088/0967-3334/25/2/006     Document Type: Article

References (16)

1. Brauer P, Kochs E, Werner C, Bloom M, Policare R, Pentheny S, Yonas H, Kofke W A and Schulte am Esch J 1998 Correlation of transcranial Doppler sonography mean flow velocity with cerebral blood flow in patients with intracranial pathology J. Neurosurg. Anesthesiol. 10 80-5
2. Bunker M L and McWilliams M 1979 Caffeine content of common beverages J. Am. Diet. Assoc. 74 28-32
3. Cameron O G, Modell J G and Hariharan M 1990 Caffeine and human cerebral blood flow: a positron emission tomography study Life Sci. 47 1141-6
4. Dahl A, Lindegaard K-F, Russell D, Nyberg-Hansen R, Rootwelt K, Sorteberg W and Nornes H 1992 A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity Stroke 23 15-9
5. Demolis P, Tran Dinh Y R and Giudicelli J-F 1996 Relationships between cerebral regional blood flow velocities and volumetric blood flows and their respective reactivities to acetazolamide Stroke 27 1835-9
6. Field A S, Laurienti P J, Yen Y-F, Burdette J H and Moody D M 2003 Dietary caffeine consumption and withdrawal: confounding variables in quantitative cerebral perfusion studies? Radiology 227 129-35
7. Giller C A, Bowman G, Dyer H, Mootz L and Krippner W 1993 Cerebral arterial diameters during changes in blood pressure and carbon dioxide during craniotomy Neurosurgery 32 737-42
8. Huber P and Handa J 1967 Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papavarine on the diameter of the cerebral arteries. Angiographic determination in man Invest. Radiol. 2 17-32
9. Kaufmann A M, Firlik A D, Fukui M B, Wechsler L R, Jungries C A and Yonas H 1999 Ischemic core and penumbra in human stroke Stroke 30 93-9
10. Kontos H A 1989 Validity of cerebral artery blood flow calculations from velocity measurements (editorial) Stroke 20 1-3
11. Lunt M J, Jenkinson D F and Kerr D 2000 Transcranial Doppler blood velocity measurement-the effect of changes in velocity profile Ultrasound Med. Biol. 26 1145-51
12. Lunt M J, Hanrahan A, Kerr D and Jenkinson D F 2002 Measuring caffeine-induced changes in middle cerebral artery blood velocity using transcranial Doppler in patients recovering from ischaemic stroke Physiol. Meas. 23 375-83
13. Mathew R J and Wilson W H 1985 Caffeine induced changes in cerebral circulation Stroke 16 814-7
14. Newell D W and Aaslid R 1992 Transcranial Doppler: clinical and experimental uses Cerebrovasc. Brain Metab. Rev. 4 122-43
15. Obrist W D and Wilkinson W E 1990 Regional Cerebral Blood Flow Measurement in Humans by Xenon-133 Clearance Cerebrovasc. Brain Metab. Rev. 2 283-327
16. Risberg J and Prohovnik I 1981 rCBF measurements by 133-Xenon inhalation: recent methodological advances Prog. Nucl. Med. 7 70-81